Recent Advances in Nanoscale Sprayable Hydrogels for Cancer Management: Nanoparticle-Loaded Formulations for Therapy and Prevention
Sprayable hydrogels applied during cancer surgery show promise in preventing local tumor recurrence in preclinical studies.
This review categorizes sprayable hydrogel platforms by cancer type, mechanism, and therapeutic goal, documenting quantitative improvements in preclinical tumor suppression including over 80% reduction in local recurrence at surgical margins. Clinical translation remains constrained by technical and regulatory challenges, and no human trial data are included.
What the study was
- Study design
- Narrative review of preclinical literature
- Population
- Various cancer types (preclinical models; peritoneal carcinomatosis, skin tumors, mucosal lesions)
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- International Journal of Nanomedicine
Why it surfaced
Review of preclinical data only; no human data; low novelty versus existing literature. Useful for technology tracking but low triage priority.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.